Ilika PLC (GB:IKA)
LSE:IKA
Advertisement

Ilika plc (IKA) AI Stock Analysis

Compare
89 Followers

Top Page

GB:IKA

Ilika plc

(LSE:IKA)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 4o)
Rating:43Neutral
Price Target:
40.00p
▼(-12.09% Downside)
Ilika plc's overall stock score is primarily impacted by its poor financial performance, characterized by declining revenues and negative profitability. Technical analysis provides some support with mild positive momentum, but valuation remains unattractive due to negative earnings. The absence of earnings call data and corporate events limits further insights.

Ilika plc (IKA) vs. iShares MSCI United Kingdom ETF (EWC)

Ilika plc Business Overview & Revenue Model

Company DescriptionIlika plc engages in the design, development, and production of solid-state batteries under the Stereax name primarily in the United Kingdom, Asia, rest of Europe, and North America. It offers batteries for a range of applications in the industrial Internet of Things, medical, transportation, electric vehicles, and cordless consumer electronics/ smart cities. The company was founded in 2004 and is headquartered in Romsey, the United Kingdom.
How the Company Makes MoneyIlika plc generates revenue primarily through the commercialization of its solid-state battery technology and materials. The company monetizes its innovations through strategic partnerships with automotive and electronics manufacturers, licensing agreements, and the sale of prototype units. Additionally, Ilika engages in research and development contracts, which provide funding and facilitate collaborations aimed at advancing battery technology. The increasing demand for efficient and safe energy storage solutions, especially in the electric vehicle market, significantly contributes to Ilika's revenue potential.

Ilika plc Earnings Call Summary

Earnings Call Date:Jan 21, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Jan 27, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted significant advancements in both Stereax and Goliath battery developments, successful partnerships, and robust patent protection. However, these positives were tempered by financial challenges, including decreased turnover and cash balance, as well as delays in full production and reliance on future grant funding. Overall, the sentiment is cautiously optimistic with balanced prospects.
Q2-2025 Updates
Positive Updates
Successful Commissioning with Cirtec
Ilika completed the commissioning of equipment at Cirtec Medical's site, marking an important step towards Stereax battery production and future revenue streams.
Progress in Goliath Battery Development
The company achieved a 10 amp-hour capacity in its Goliath batteries, representing a fivefold increase from previous prototypes, indicating significant progress in development.
Strong Patent Portfolio
Ilika has secured 62 patents in important jurisdictions worldwide, providing robust protection for their solid-state battery technology.
Strategic Partnerships and Market Interest
Engagement with 21 OEMs and Tier 1 companies for automotive and consumer electronics applications shows strong market interest in Ilika's technology.
Balanced Financial Management
Despite a slight decrease in turnover to £1 million, Ilika maintained its EBITDA loss at £1.9 million, demonstrating effective cost management.
Negative Updates
Turnover Decline
Turnover decreased to £1 million from previous periods, largely due to the winding down of grant funding.
Cash Balance Decline
Ilika's cash balance decreased from £13.2 million to £10.1 million, though this was partially offset by a small raise in May.
Challenges in Securing Grant Funding
There has been a hiatus in available grant funding, impacting financial projections and cash flow management.
Delay in Full Production
Full production for Stereax and Goliath batteries is not expected immediately, with timelines extending into the next 18-24 months.
Company Guidance
In the investor presentation call, Ilika plc provided guidance on its financial and operational progress, particularly focusing on their Stereax and Goliath product lines. The company highlighted its strong patent portfolio of 62 patents and emphasized its business model, which involves licensing its IP to Tier 1 manufacturing partners and OEMs. This model allows Ilika to maintain a low working capital requirement and expedite time to market while minimizing manufacturing risk. Ilika announced that its Stereax batteries, designed for medical devices and industrial IoT applications, have completed commissioning at Cirtec's facility, with production and revenue expected to commence in 2025. The call also covered the company's progress with Goliath batteries, targeting the automotive market, and detailed their safety benefits and potential to reduce EV costs. Ilika's financials showed a turnover of £1,000,000, primarily from grant funding, and an EBITDA loss of £1.9 million, consistent with the previous year. The company maintains a cash balance of £10.1 million and continues to seek grant funding and strategic partnerships to support its growth.

Ilika plc Financial Statement Overview

Summary
Ilika plc is facing significant financial challenges, with declining revenues and negative profitability across key metrics. The balance sheet shows low leverage, which is a positive sign, but the negative return on equity highlights profitability issues. Cash flow remains a concern, although there is some improvement in free cash flow. Overall, the company needs to address its operational inefficiencies and improve its revenue generation to enhance financial health.
Income Statement
20
Very Negative
Ilika plc has experienced significant revenue decline with a negative growth rate of -95.77% in the latest year. The company is facing severe profitability challenges, evidenced by negative gross profit, net profit, EBIT, and EBITDA margins. These metrics indicate substantial operational inefficiencies and a lack of profitability.
Balance Sheet
40
Negative
The balance sheet shows a low debt-to-equity ratio of 0.027, indicating minimal leverage, which is a positive aspect. However, the return on equity is negative, reflecting the company's inability to generate profits from shareholders' equity. The equity ratio is relatively stable, suggesting a moderate level of financial stability.
Cash Flow
30
Negative
Cash flow analysis reveals a negative operating cash flow and free cash flow, though there is a positive free cash flow growth rate of 27.83%. The operating cash flow to net income ratio is negative, indicating cash flow challenges. The free cash flow to net income ratio is above 1, suggesting some efficiency in converting net income to free cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue982.90K73.50K20.10K33.85K30.88K230.45K
Gross Profit-453.90K-452.70K-1.06M-1.97M-1.49M-1.06M
EBITDA-5.62M-5.38M-4.00M-7.30M-6.81M-2.68M
Net Income-5.90M-5.90M-4.81M-7.30M-7.13M-3.53M
Balance Sheet
Total Assets19.45M19.45M22.83M26.91M33.93M16.53M
Cash, Cash Equivalents and Short-Term Investments7.98M7.98M11.95M15.87M23.45M9.82M
Total Debt470.70K470.70K625.30K618.48K847.60K827.72K
Total Liabilities2.27M2.27M2.47M2.14M2.50M2.34M
Stockholders Equity17.18M17.18M20.36M24.77M31.44M14.19M
Cash Flow
Free Cash Flow-5.09M-6.28M-4.13M-7.45M-10.08M-4.95M
Operating Cash Flow-4.02M-4.18M-2.46M-6.05M-5.64M-2.13M
Investing Cash Flow2.07M2.47M-5.06M-1.40M-4.44M-2.83M
Financing Cash Flow1.93M1.93M-316.70K-75.78K23.71M-32.94K

Ilika plc Technical Analysis

Technical Analysis Sentiment
Positive
Last Price45.50
Price Trends
50DMA
42.71
Positive
100DMA
42.01
Positive
200DMA
39.29
Positive
Market Momentum
MACD
0.50
Negative
RSI
54.38
Neutral
STOCH
82.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IKA, the sentiment is Positive. The current price of 45.5 is above the 20-day moving average (MA) of 44.90, above the 50-day MA of 42.71, and above the 200-day MA of 39.29, indicating a bullish trend. The MACD of 0.50 indicates Negative momentum. The RSI at 54.38 is Neutral, neither overbought nor oversold. The STOCH value of 82.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:IKA.

Ilika plc Risk Analysis

Ilika plc disclosed 6 risk factors in its most recent earnings report. Ilika plc reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Ilika plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
60
Neutral
£747.34M-21.06-23.26%12.58%12.39%
56
Neutral
£104.83M15.77%-3.32%10.13%
45
Neutral
£5.62M-25.30-1.39%-10.88%-122.05%
43
Neutral
£76.85M-12.04-31.45%265.67%-16.50%
41
Neutral
£98.44M-3.80-86.37%732.03%12.60%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:IKA
Ilika plc
45.50
29.25
180.00%
GB:AFC
AFC Energy
9.10
-0.20
-2.15%
GB:CWR
Ceres Power Holdings
384.40
208.00
117.91%
GB:DIA
Dialight
290.00
163.50
129.25%
GB:LPA
LPA Group plc
42.50
-18.00
-29.75%
GB:GELN
Gelion PLC
20.50
2.50
13.89%

Ilika plc Corporate Events

Business Operations and StrategyProduct-Related Announcements
Ilika Completes Goliath Pilot Line, Boosting Solid-State Battery Production
Positive
Oct 21, 2025

Ilika plc has announced the completion of its Goliath automated pilot line, marking a significant milestone in its solid-state battery production capabilities. This development enables the company to deliver 10Ah and 50Ah battery prototypes to customers, supporting internal and commercial testing programs. The pilot line’s operational status enhances manufacturing yield and consistency, positioning Ilika to meet the demands of its stakeholders and advance its commercialization and licensing objectives. Collaborations with UK Battery Industrialisation Centre and other partners will further scale up production, particularly for automotive applications.

The most recent analyst rating on (GB:IKA) stock is a Hold with a £39.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.

Business Operations and StrategyProduct-Related Announcements
Ilika plc Completes Commissioning of Goliath Automated Pilot Line
Positive
Oct 21, 2025

Ilika plc has announced the successful commissioning of its Goliath automated pilot line, marking a significant step in its solid-state battery production capabilities. This development allows Ilika to deliver solid-state battery prototypes to customers, enhancing manufacturing yield and consistency. The pilot line’s operational status supports the delivery of 10Ah and 50Ah battery prototypes for customer testing and validation, aligning with Ilika’s commercialisation strategy. The company plans to further scale production in collaboration with the UK Battery Industrialisation Centre and other partners, reinforcing its position in the battery technology industry and advancing towards its licensing objectives.

The most recent analyst rating on (GB:IKA) stock is a Hold with a £39.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.

Delistings and Listing ChangesPrivate Placements and Financing
Ilika plc Announces New Share Issuance and Trading Admission
Neutral
Oct 1, 2025

Ilika plc has announced the issuance of 30,000 new ordinary shares following the exercise of options under its share option schemes. These shares are expected to be admitted for trading on AIM by October 6, 2025. This move will increase the company’s total issued share capital to 180,832,175 ordinary shares, which will be used by shareholders for calculating their interest in the company. This development reflects Ilika’s ongoing efforts to enhance its financial structure and market presence.

The most recent analyst rating on (GB:IKA) stock is a Hold with a £39.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.

Business Operations and StrategyShareholder Meetings
Ilika plc Reports Successful AGM and Executive Share Option Awards
Positive
Sep 23, 2025

Ilika plc announced the successful passing of all resolutions at its recent Annual General Meeting, reflecting strong shareholder support. The company also granted share options to its executive directors as part of its deferred Bonus Scheme, indicating a strategic move to align management interests with company performance.

The most recent analyst rating on (GB:IKA) stock is a Sell with a £33.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.

Business Operations and StrategyProduct-Related Announcements
Ilika Launches PRIMED Solid-State Battery Programme with Key Automotive Support
Positive
Sep 22, 2025

Ilika plc has announced the commencement of its PRIMED solid-state battery programme, supported by key partners including Jaguar Land Rover and Oxford University. The programme aims to advance the commercialisation of Ilika’s solid-state battery technology by leveraging the UK Battery Industrialisation Centre’s facilities to scale up production. This initiative builds on previous successful projects and is expected to deliver critical outcomes such as prototype cells and a production scale model, positioning Ilika to accelerate the industrialisation of its Goliath technology for the electric vehicle market.

The most recent analyst rating on (GB:IKA) stock is a Sell with a £33.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.

Business Operations and StrategyShareholder Meetings
Ilika plc Announces AGM Date and Investor Presentation
Neutral
Aug 28, 2025

Ilika plc has announced the date for its Annual General Meeting (AGM) and the posting of its Annual Report for the year ended 30 April 2025. The AGM is scheduled for 23 September 2025, and shareholders are encouraged to vote online or appoint a proxy. The company will not conduct a business operations presentation or Q&A session at the AGM but will host a separate investor presentation through the Investor Meet Company platform. This announcement highlights Ilika’s ongoing commitment to engaging with its stakeholders and providing transparency about its operations and strategic direction.

The most recent analyst rating on (GB:IKA) stock is a Hold with a £34.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.

Business Operations and StrategyProduct-Related Announcements
Ilika and Cirtec Medical Achieve Milestone in Micro-Battery Production
Positive
Aug 18, 2025

Ilika plc, in partnership with Cirtec Medical, has achieved a significant milestone in the production of its Stereax micro-batteries, completing the manufacturing process qualification at Cirtec’s US facility. This advancement marks the beginning of production for product testing and initial customer deliveries, enhancing miniaturization capabilities for implantable medical devices. The collaboration combines Ilika’s advanced battery technology with Cirtec’s manufacturing expertise, positioning both companies to meet the growing demand for miniaturized medical implants.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 06, 2025